Your browser is no longer supported. Please, upgrade your browser.
Settings
AMPE Ampio Pharmaceuticals, Inc. daily Stock Chart
AMPE [NYSE]
Ampio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.49 Insider Own0.50% Shs Outstand53.76M Perf Week7.16%
Market Cap54.30M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float53.76M Perf Month6.33%
Income-25.80M PEG- EPS next Q- Inst Own33.40% Short Float11.27% Perf Quarter34.45%
Sales0.50M P/S108.60 EPS this Y18.90% Inst Trans0.26% Short Ratio15.71 Perf Half Y-1.94%
Book/sh0.18 P/B5.61 EPS next Y- ROA-97.90% Target Price14.00 Perf Year-53.88%
Cash/sh0.14 P/C7.05 EPS next 5Y- ROE-132.70% 52W Range0.59 - 4.32 Perf YTD12.20%
Dividend- P/FCF- EPS past 5Y-4.50% ROI- 52W High-76.62% Beta0.29
Dividend %- Quick Ratio3.40 Sales past 5Y- Gross Margin48.00% 52W Low71.19% ATR0.08
Employees21 Current Ratio3.40 Sales Q/Q- Oper. Margin- RSI (14)58.30 Volatility7.17% 8.38%
OptionableYes Debt/Eq0.41 EPS Q/Q21.00% Profit Margin- Rel Volume1.03 Prev Close0.95
ShortableYes LT Debt/Eq0.41 EarningsNov 03 AMC Payout- Avg Volume385.61K Price1.01
Recom2.00 SMA206.17% SMA5020.64% SMA200-42.74% Volume392,454 Change6.29%
Mar-17-14Reiterated Aegis Capital Buy $15 → $16
Sep-25-12Initiated Aegis Capital Buy $11
Jan-10-17 04:06PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-15-16 01:04PM  AMPIO PHARMACEUTICALS, INC. Financials
Nov-10-16 08:05AM  Ampio Updates Clinical and Regulatory Activity PR Newswire
Nov-08-16 08:09AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Oct-04-16 08:30AM  Ampio Announces Accepted Publication of the Clinical Trial Results of Its Oral Drug, Optina, Treatment of Diabetic Macular Edema PR Newswire
Sep-29-16 02:50PM  Ampio Updates Clinical and Regulatory Activity PR Newswire
Sep-08-16 12:08PM  Ampio Reports Peer-Reviewed Publication on the Potential use of Ampion in New Clinical Indications PR Newswire
Aug-30-16 08:00AM  Ampio Reports Additional Peer-Reviewed Publication on Ampion PR Newswire
Aug-29-16 05:29PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and -8.85%
11:07AM  Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire
Aug-03-16 08:00AM  Ampio Updates Regulatory Status of AMPION PR Newswire
06:20AM  Ampio reports 2Q loss
Aug-02-16 04:09PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Jul-13-16 07:17AM  7 Stocks Under $10 That Could Make You a Lot of Money
Jul-05-16 01:30PM  Ampio Hosting Conference Call Today, July 5, 4:30pm ET PR Newswire
08:00AM  Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE) at Insider Monkey
Jul-03-16 09:35AM  4 Companies That Destroyed Shareholders Despite a Brexit Recovery at 24/7 Wall St.
Jun-30-16 03:57PM  Why Ampio Pharma (AMPE) Stock Is Plummeting Today -61.14%
01:42PM  Ampio Crashes After Late-Stage Trial Failure
08:38AM  Ampio Pharma stock plummets 55% after negative late-stage trial results at MarketWatch
08:38AM  Ampio Pharma stock plummets 55% after negative late-stage trial results at MarketWatch
08:05AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Ampio announces results of Ampion trials PR Newswire
May-10-16 08:30AM  Ampio Launches Clinical Trial of AMPION for the Treatment of Osteoarthritis of the Hand PR Newswire
May-06-16 09:07AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
May-03-16 08:30AM  Ampio Reports Additional Peer-Reviewed Publications on Ampion PR Newswire
Mar-29-16 04:45PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
09:19AM  Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION March 29, 2016 at noodls
09:03AM  Ampio Completes Enrollment in Pivotal Clinical Trial of AMPION PR Newswire
Mar-07-16 04:45PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Feb-26-16 09:25AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
Feb-11-16 07:30AM  Ampio Clarifies ATM Program PR Newswire
Feb-10-16 04:46PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
Jan-29-16 09:02AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure +5.31%
Jan-26-16 08:59AM  Ampios OptimEyes Study Results to be presented at The Association for Research in Vision and Ophthalmology (ARVO) January 26, 2016 at noodls
08:30AM  Ampio's OptimEyes Study Results to be presented at The Association for Research in Vision and Ophthalmology (ARVO) PR Newswire
Jan-25-16 08:37AM  Ampio Announces 2016 Corporate Update on Thursday, January 28, 4:30pm EST January 25, 2016 at noodls
08:30AM  Ampio Announces 2016 Corporate Update on Thursday, January 28, 4:30pm EST PR Newswire
Jan-11-16 08:30AM  Ampio's OptimEyes Study Results to be presented at World Ophthalmology Congress PR Newswire -5.93%
Dec-24-15 10:24AM  Ampio Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-18-15 07:35AM  How it All Plays Out - Free Research Reports on Hill International, Marinus Pharmaceuticals, Ampio Pharmaceuticals and Cutera Accesswire
Dec-16-15 04:12PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Dec-01-15 08:30AM  The NYSE Establishes January 5, 2016 as the Ex-Distribution Date for the Ampio Distribution of Aytu BioScience Stock to Ampio Shareholders PR Newswire
Nov-23-15 07:50AM  Equity Market Movement at a Glance - Research on AxoGen, Ampio Pharmaceuticals, Ultra Clean Holdings and Willbros Group Accesswire
Nov-19-15 08:00AM  Aytu BioScience to Benefit from Share Distribution by Ampio Pharmaceuticals PR Newswire +6.15%
Nov-18-15 08:30AM  Ampio Announces Investor Call on its Aytu BioScience Common Stock Distribution on Thursday, November 19, 4:15 p.m. EST PR Newswire -5.21%
07:07AM  Q3 2015 Ampio Pharmaceuticals Inc Earnings Release - Time Not Supplied
Nov-17-15 04:51PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  Ampio Will Distribute Aytu BioSciences Stock to Ampio Shareholders of Record on December 1, 2015 PR Newswire
Nov-06-15 04:32PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Nov-05-15 04:25PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-02-15 08:32AM  Ampio Intends to Distribute Aytu BioScience Stock to Ampio Shareholders PR Newswire
Oct-20-15 04:05PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
Oct-14-15 09:00AM  Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA Approval of Optina, an Oral Treatment for Diabetic Macular Edema (DME) PR Newswire
Oct-13-15 04:32PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
Oct-08-15 04:08PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
Oct-01-15 11:08AM  Ampio Pharmaceuticals, Inc. Earnings Q2, 2015
Sep-24-15 09:29AM  Opening Bell, September 24, 2015 +13.10%
Sep-23-15 05:32PM  Ampio (AMPE) Starts Final Phase III Study on Knee Pain Drug -7.12%
Sep-22-15 12:46PM  Ampio Pharmaceuitcals (AMPE) Stock Spikes After Receiving FDA Special Protocol Assessment at TheStreet +5.97%
11:25AM  Is the Surge in Ampio Sustainable?
08:00AM  AMPIO Receives Special Protocol Assessment (SPA) from the FDA and Commences Second Phase III pivotal trial of Ampion PR Newswire
Aug-10-15 08:13PM  10-Q for Ampio Pharmaceuticals, Inc. at Company Spotlight
Aug-07-15 08:04AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report +9.76%
Aug-06-15 08:02AM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
Jul-17-15 11:30AM  Ampio Hosts Investor Call to Discuss Updates on Ampion and Optina PR Newswire
Jul-09-15 12:10PM  Ampio Announces Investor Call on Thursday, July 16, 4:30 p.m. EDT PR Newswire
Jul-06-15 10:41AM  24-Hour Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of July 7 Deadline in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. Investors Business Wire
Jul-03-15 10:46PM  IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm Prior to the Lead Plaintiff Deadline Business Wire
Jul-01-15 03:30PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2015 -- AMPE GlobeNewswire +5.49%
11:57AM  INVESTOR ALERT: Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. Announced by Glancy Prongay & Murray LLP Business Wire
Jun-30-15 08:45PM  IMPORTANT SHAREHOLDER ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Reminds Investors That a Federal Securities Class Action Has Been Filed Against Ampio Pharmaceuticals, Inc. - AMPE GlobeNewswire -5.20%
Jun-26-15 05:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - AMPE PR Newswire -5.84%
Jun-23-15 10:23AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 10, 2015 -- AMPE Marketwired
Jun-22-15 08:30AM  Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina in the Treatment of Diabetic Macular Edema (DME) PR Newswire
Jun-18-15 06:56PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Ampio Pharmaceuticals, Inc. Of Upcoming Deadline Business Wire +8.00%
Jun-16-15 05:45PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ampio Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 10, 2015 -- AMPE GlobeNewswire
08:30AM  Ampio Pharmaceuticals Provides Information on the Formation and Significance of Aytu BioScience to Ampio Shareholders PR Newswire
Jun-15-15 07:00PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Ampio Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
Jun-13-15 08:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline AMPE GlobeNewswire
Jun-12-15 06:40PM  TRADING ALERT: The Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important July 7, 2015 Deadline - AMPE GlobeNewswire
04:35PM  INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Ampio Pharmaceuticals, Inc. (AMPE) to Contact the Firm Marketwired
Jun-10-15 11:29AM  AMPE INVESTOR ALERT: Investigation of Ampio Pharmaceuticals, Inc. Announced by Glancy Prongay & Murray LLP Business Wire
Jun-09-15 08:30AM  Ampio Pharmaceuticals Reports the Synergistic Effects of Ampion in the Treatment of Osteoarthritis of the Knee in Three Peer-reviewed Publications PR Newswire
Jun-05-15 08:26PM  INVESTOR ALERT: Investigation of Ampio Pharmaceuticals, Inc. Announced by The Law Offices of Howard G. Smith Business Wire
Jun-04-15 08:00AM  Ampio Pharmaceuticals Announces Update of STRIDE Study for the Investigation of Pain Associated with Osteoarthritis PR Newswire +5.64%
Jun-01-15 06:12PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Ampio Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - AMPE GlobeNewswire
May-29-15 04:05PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Ampio Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AMPE GlobeNewswire
May-27-15 04:08PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events +5.86%
May-26-15 04:12PM  AMPIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi
May-22-15 05:26PM  ALERT: The Rosen Law Firm Reminds Ampio Pharmaceuticals, Inc. Investors of Important Deadline Business Wire -5.81%
04:05PM  Ampio Pharmaceuticals Shoots up on Positive Optina Data - Analyst Blog
May-21-15 08:00AM  Ampio Pharmaceuticals Announces Positive Study Results on Optina for the Treatment of Diabetic Macular Edema PR Newswire +18.72%
May-20-15 03:10PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ampio Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit - AMPE PR Newswire -5.14%
May-18-15 07:00PM  IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against Ampio Pharmaceuticals, Inc. -- AMPE GlobeNewswire
09:11AM  Law Offices of Marc S. Henzel Announces Securities Class Action Periods PR Newswire
May-14-15 07:26PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Ampio Pharmaceuticals, Inc. and Certain Officers -- AMPE GlobeNewswire
May-12-15 08:48PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Ampio Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit AMPE GlobeNewswire
May-11-15 08:12PM  10-Q for Ampio Pharmaceuticals, Inc. at Company Spotlight
07:02PM  Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. (AMPE) GlobeNewswire
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. Its product pipeline includes Ampion for the treatment of osteoarthritis of the knee; and Optina that is in Phase IIb clinical trial for diabetic macular edema. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.